Arcutis Biotherapeutics, Inc.

This is the first study in humans testing a new drug called ARQ-234 for moderate to severe eczema (atopic dermatitis). Researchers will give single and multiple doses to healthy volunteers and people with eczema to check if it's safe, how the body processes it, and if it shows ea…

This early-stage study is testing a new foam treatment for scalp and body psoriasis in children. Researchers want to see how much of the medicine gets into the bloodstream and check for any side effects when it's used daily. The study will include 16 children between the ages of …